Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

Genetic Related News

New Hope for SPG47: BlackfinBio’s BFB-101 Gene Therapy Advances with FDA Approval
How Ring's Anellovectors Could Change the Treatment of Genetic Diseases
The Next Frontier: Revolutionizing Gene Therapy with Anellovirus-Based Vectors
Pioneering Gene Therapy Shows Promising Results in Parkinson’s Disease Trial
Mitochondrial Discovery: A New Era in Parkinson's Prevention and Treatment
Researchers discover key connection between DNA replication and cancer
Could Utilizing DNA Repair Mechanisms Be an Option in Cancer Treatment?

Most Popular

Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization

Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults

FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults

A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH

A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH

Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR

Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global

NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment

NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment

EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer

EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer

FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis

FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis

Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases

Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases

Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B

Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B

NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer

NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer

FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma

FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma

New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages

New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages

FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma

FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma